🔎 Trials Near Me

ホーム › 肥満症 › バージニア

バージニアにおける肥満症の臨床試験

バージニア内の拠点で、肥満症に関する43件の研究が参加者を募集しています。

バージニア内の都市

公式研究テキスト(英語)

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

  • Washington Center For Weight Management And Research /ID# 282047, Arlington
  • Sovah Health - Danville /ID# 282876, Danville
  • Health Research Of Hampton Roads /ID# 282014, Newport News
  • 他1件
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/10/02更新 · NCT07752979

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Carient Heart & Vascular - Manassas, Manassas
  • Carient Heart and Vascular LLC-Reston, Reston
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07783802

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

  • National Clin Res Inc., Richmond
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07533175

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

  • Washington Cntr Weight Mgmt, Arlington
  • Health Res of Hampton Roads, Newport News
  • National Clin Res Inc., Richmond
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

  • National Clin Res Inc., Richmond
  • Gastroent Consult of SW VA, Roanoke
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07668414

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  • York Clinical Research, LLC, Norfolk
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07595549

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  • VCU Health - Center for Endocrinology Diabetes and Metabolism, Richmond
被験者募集中第3相
6歳〜17歳 · 全性別 · 2026/09/24更新 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Gastroenterology Consultants of Southwest Virginia, Roanoke
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937086

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

  • Washington Cntr Weight Mgmt, Arlington
  • Health Res of Hampton Roads, Newport News
  • Selma Medical Associates, Winchester
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/24更新 · NCT07339423

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Manassas
  • Research Site, Norfolk
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Inova Cardiology - Fairfax, Fairfax
  • Virginia Heart, Falls Church
被験者募集中第3相
45歳〜99歳 · 全性別 · 2026/09/22更新 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

  • AMR Clinical, Norfolk
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07321886

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

  • Charlottesville Medical Research, Charlottesville
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

  • Sovah Clinical Research-River District, Danville
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/22更新 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

  • AURORA-1 Clinical Site, Hampton
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Hampton
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • Conquest Research, LLC, Arlington
  • Virginia Heart, Falls Church
  • Carient Heart and Vascular, Manassas
  • 他2件
被験者募集中第3相
18歳〜99歳 · 全性別 · 2026/09/16更新 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Manassas Clinical Research Center, Manassas
  • Centricity Research Suffolk Primary Care, Suffolk
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/14更新 · NCT07351058

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

  • ACCOMPLISH-2 Research Site, Burke
  • ACCOMPLISH-2 Research Site, Manassas
  • ACCOMPLISH-2 Research Site, Suffolk
被験者募集中第3相健康なボランティア歓迎
18歳〜79歳 · 全性別 · 2026/09/11更新 · NCT07654374

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

  • Selma Medical Associates, Winchester
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07770841

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

  • Sovah Clinical Research-River District, Danville
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/08更新 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

  • Eastern Virginia Medical School (EVMS) Medical Group, Norfolk
  • Clinical Research Partners, LLC, Richmond
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/08更新 · NCT07215559

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

  • Health Res of Hampton Roads, Newport News
  • National Clin Res Inc., Richmond
  • Selma Medical Associates, Winchester
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/04更新 · NCT07745504

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

  • Kailera Clinical Site, Manassas
  • Kailera Clinical Site, Richmond
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  • Washington Center for Weight Management and Research, Inc, Arlington
  • Health Research of Hampton Roads, Newport News
  • Selma Medical Associates, Winchester
被験者募集中第3相
18歳〜99歳 · 全性別 · 2026/09/03更新 · NCT07684235

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

  • Kailera Clinical Site, Danville
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT07284875

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

  • Manassas Clinical Research Center Inc, Manassas
被験者募集中第3相
18歳〜99歳 · 全性別 · 2026/09/03更新 · NCT07684144

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

  • Kailera Clinical Site, Manassas
  • Kailera Clinical Site, Richmond
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/01更新 · NCT07284979

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

  • Research Site, Arlington
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/25更新 · NCT07784725

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  • University Of Virginia Hospital, Charlottesville
  • Carient Heart and Vascular, Manassas
  • TPMG Clinical Research, Newport News
  • 他4件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/18更新 · NCT07567001

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

  • Health Res of Hampton Roads, Newport News
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/17更新 · NCT07509307

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

  • Charlottesville Medical Research, Charlottesville
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/07/22更新 · NCT07477704

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

  • Charlottesville Med Research, Charlottesville
  • Health Res of Hampton Roads, Newport News
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/09更新 · NCT07481630

Brief Inhibitory Training for Eating - Intervention

  • George Mason University, Fairfax
被験者募集中
14歳〜17歳 · 全性別 · 2026/06/17更新 · NCT07592728

Advancing Water Security: A Community Participatory School-Based Hydration Intervention

  • Children's Hospital of Richmond at VCU Healthy Lifestyles Center, Henrico
被験者募集中健康なボランティア歓迎
4歳以上 · 全性別 · 2026/06/10更新 · NCT06714929

Redefining BMI: The Body, Mind, and Inflammation Trial

  • Virginia Commonwealth Universtity, Richmond
被験者募集中
18歳〜25歳 · 女性 · 2026/05/06更新 · NCT06532747

A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use

  • Vanda Investigational Site, Burke
被験者募集中第3相健康なボランティア歓迎
18歳〜65歳 · 全性別 · 2026/04/20更新 · NCT07446439

Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy

  • University of Virginia Medical Center, Charlottesville
被験者募集中第2相
12歳〜21歳 · 全性別 · 2026/04/17更新 · NCT06903923

Examining Valence-based Effects in Self-Monitoring Feedback Messages

  • University of Virginia, Charlottesville
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/03/31更新 · NCT07292389

ClinicalTrials.govより、2026/10/03時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。